AORTAFIT
DEAD

Serial Number

90003521

Owner

Bolton Medical, Inc.

Attorney

Joshua Jarvis, Esq.

Filing Date

Jun 16, 2020

Add to watchlist:

No watchlists yet
View on USPTO

AORTAFIT Trademark

Serial Number: 90003521

AORTAFIT is a trademark filed by Bolton Medical, Inc. on June 16, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Bolton Medical, Inc. (29 trademarks)

799 International Parkway
Sunrise, FL 33325

Entity Type: 03

Aortica Corporation (8 trademarks)

11811 NE 1st Street, Suite 311
Bellevue, WA 98005

Entity Type: 03

Trademark Details

Filing Date

June 16, 2020

Registration Date

Not Registered

Published for Opposition

May 4, 2021

Goods & Services

Downloadable software for evaluating patient-specific data, generating case planning information, and providing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; downloadable software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices

Medical assistance and analysis, namely, evaluating patient-specific data, generating case planning information, and providing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; medical assistance and analysis, namely, evaluating patient- specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices

Software as a service (SaaS) services featuring software for evaluating patient-specific data, generating case planning information, and providing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; software as a service (SaaS) services featuring software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing online non-downloadable software for evaluating patient-specific data, generating case planning information, and proposing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing temporary use of non-downloadable cloud-based software for evaluating patient-specific data, generating case planning information, and proposing patient-specific device configurations for use by surgeons in preparing for procedures involving blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing online non-downloadable software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices; providing temporary use of non-downloadable cloud-based software for evaluating patient-specific data and generating patient-specific device configurations for use by manufacturers to provide patient-specific blood vessel grafts, blood vessel stent grafts, endografts, fenestrated endografts, and related devices

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 5, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 5, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 9, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jan 8, 2024 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 8, 2024 AITU
SOU EXTENSION 5 FILED
Dec 15, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 15, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 30, 2023 EXRA
SOU EXTENSION 4 GRANTED
May 26, 2023 EX4G
SOU EXTENSION 4 FILED
May 26, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
May 26, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 7, 2022 EXRA
SOU EXTENSION 3 GRANTED
Dec 5, 2022 EX3G
SOU EXTENSION 3 FILED
Dec 5, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 5, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 4, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jun 2, 2022 EX2G
SOU EXTENSION 2 FILED
Jun 2, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 2, 2022 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 20, 2022 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 14, 2021 EXRA
SOU EXTENSION 1 GRANTED
Dec 10, 2021 EX1G
SOU EXTENSION 1 FILED
Dec 10, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 10, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 29, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 4, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 4, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2021 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Sep 23, 2020 GPRN
PRIORITY ACTION E-MAILED
Sep 23, 2020 GPRA
PRIORITY ACTION WRITTEN
Sep 23, 2020 CPRA
ASSIGNED TO EXAMINER
Sep 18, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2020 NWOS
NEW APPLICATION ENTERED
Jun 19, 2020 NWAP